Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Snyder

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Immunotherapy|January 21, 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vectorMichael Quinn, Dan A Erkes, Christopher M Snyder
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cellsChristopher M Snyder, Xianghua Zhang, Lawrence J Wysocki
Health Affairs (Project Hope)|August 9, 2011
Economic perspectives on the advance market commitment for pneumococcal vaccinesChristopher M Snyder, Wills Begor, Ernst R Berndt
Human Vaccines & Immunotherapeutics|June 13, 2017
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunityDan A Erkes, Nicole A Wilski, Christopher M Snyder
Molecular Biology of the Cell|October 28, 2005
Cis-Golgi matrix proteins move directly to endoplasmic reticulum exit sites by association with tubulesGonzalo A Mardones, Christopher M Snyder, Kathryn E Howell
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2016
Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic CellsChristopher P Loo, Christopher M Snyder, Ann B Hill
International Journal of Industrial Organization|April 11, 2022
Optimal vaccine subsidies for endemic diseasesMatthew Goodkin-Gold, Michael Kremer, Christopher M Snyder, et al.
Medical Microbiology and Immunology|March 9, 2019
Persistent viral replication and the development of T-cell responses after intranasal infection by MCMVShunchuan Zhang, Sofia Caldeira-Dantas, Corinne J Smith, et al.
Cell Reports|November 4, 2015
Murine CMV Infection Induces the Continuous Production of Mucosal Resident T CellsCorinne J Smith, Sofia Caldeira-Dantas, Holly Turula, et al.
Health Affairs (Project Hope)|July 24, 2020
Designing Pull Funding For A COVID-19 VaccineChristopher M Snyder, Kendall Hoyt, Dimitrios Gouglas, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Immunotherapy|January 21, 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vectorMichael Quinn, Dan A Erkes, Christopher M Snyder
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cellsChristopher M Snyder, Xianghua Zhang, Lawrence J Wysocki
Health Affairs (Project Hope)|August 9, 2011
Economic perspectives on the advance market commitment for pneumococcal vaccinesChristopher M Snyder, Wills Begor, Ernst R Berndt
Human Vaccines & Immunotherapeutics|June 13, 2017
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunityDan A Erkes, Nicole A Wilski, Christopher M Snyder
Molecular Biology of the Cell|October 28, 2005
Cis-Golgi matrix proteins move directly to endoplasmic reticulum exit sites by association with tubulesGonzalo A Mardones, Christopher M Snyder, Kathryn E Howell
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2016
Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic CellsChristopher P Loo, Christopher M Snyder, Ann B Hill
International Journal of Industrial Organization|April 11, 2022
Optimal vaccine subsidies for endemic diseasesMatthew Goodkin-Gold, Michael Kremer, Christopher M Snyder, et al.
Medical Microbiology and Immunology|March 9, 2019
Persistent viral replication and the development of T-cell responses after intranasal infection by MCMVShunchuan Zhang, Sofia Caldeira-Dantas, Corinne J Smith, et al.
Cell Reports|November 4, 2015
Murine CMV Infection Induces the Continuous Production of Mucosal Resident T CellsCorinne J Smith, Sofia Caldeira-Dantas, Holly Turula, et al.
Health Affairs (Project Hope)|July 24, 2020
Designing Pull Funding For A COVID-19 VaccineChristopher M Snyder, Kendall Hoyt, Dimitrios Gouglas, et al.
Pageof 6